Agranulocytosis during treatment with ajmaline
Søndergaard, S.; Milman, N.
Ugeskrift for Laeger 148(17): 1026-1027
1986
ISSN/ISBN: 0041-5782 PMID: 3727064 Document Number: 276040
Document emailed within 1 workday
Related Documents
Caramella, J.P.; Guerot, C.; Valere, P.E.; Tricot, R.; Bismuth, C.; Riboulet, G. 1982: Cardiac toxicity of ajmaline. Comparison of acute voluntary poisoning with complications of the ajmaline test Archives des Maladies du Coeur et des Vaisseaux 75(5): 613-620Giannelli, C.; Gioieni, A.; Ciarletti, S. 1979: A case of intrahepatic cholestasis during treatment with ajmaline La Clinica Terapeutica 91(6): 637-639
Beermann, B.; Ericsson, J.; Hellström, K.; Wengle, B.; Werner, B. 1970: Intrahepatic cholestasis in connection with ajmaline treatment Nordisk Medicin 84(38): 1212
Corneo, G.G.; Dell'Acqua, A. 1970: Delayed ajmaline in the treatment of various arrhythmias in elderly and aged patients Minerva Medica 61(78): 4301-4305
Baedeker, W.; Rastetter, J. 1977: Agranulocytosis after treatment with apridine Münchener Medizinische Wochenschrift 119(32-33): 1047-1048
Sokolina, E.L. 1971: Agranulocytosis during ethoxide treatment Klinicheskaia Meditsina 49(12): 98-102
Sebaoun J et, A.L. 1977: Acute agranulocytosis during carbimazole treatment La Nouvelle Presse Medicale 6(31): 2778-2779
Marcer, V.; Dander, B.; Spinosa, G.; Buonanno, C. 1976: Ajmaline treatment of supraventricular paroxysmal tachycardia in Wolff-Parkinson-White syndrome. Report of a neonatal case Minerva Pediatrica 28(11): 695-700
Durkalec, J.; Kościński, R. 1971: Agranulocytosis with erythroderma following treatment of gout with Colcemid Polski Tygodnik Lekarski 26(27): 1048-1049
Negishi, M.; Yamazaki, J.; Hosaka, M.; Iwabuchi, H.; Matsuda, A.; Kanemitsu, H.; Hiramatsu, K.; Kaga, S.; Hashimoto, M.; Kasama, T. 1994: A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment Ryumachi 34(3): 651-655
Pivnik, A.V.; Tonkoglaz, V.N.; Boĭko, D.V. 2006: Haptenic agranulocytosis: treatment with hemopoietic growth factors Klinicheskaia Meditsina 84(3): 55-59
Grosbois, B.; Milon, D.; Dauriac, C.; Leprise, P.Y.; Leclech, C.; Baert, A.; Beneton, C. 1985: Hematologic disorders (acute agranulocytosis) during treatment with indalpine Presse Medicale 14(3): 163-164
Balkarova, O.V.; Fomin, V.V.; Kozlovskaia, L.V. 2005: Agranulocytosis due to cefoperazon treatment in a patient with terminal renal failure Terapevticheskii Arkhiv 77(6): 76-78
Hospers, G.A.; de Wolf, J.T.; Hazenberg, B.P.; Vellenga, E. 1993: Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis Nederlands Tijdschrift Voor Geneeskunde 137(42): 2152-2154
Joseph, F.; Younis, N.; Bowen-Jones, D. 2003: Treatment of carbimazole-induced agranulocytosis and sepsis with granulocyte colony stimulating factor International Journal of Clinical Practice 57(2): 145-146
Marcos Sánchez, F.; Juárez Ucelay, F.; Barbudo Ousset, M.; Durán Pérez-Navarro, A. 1993: Granulocyte colony stimulating factors in the treatment of agranulocytosis causing sepsis of respiratory origin Anales de Medicina Interna 10(4): 206-207
Wruck, C.; Hofmann, H.; Sziegoleit, W.; Förster, W. 1982: Oral treatment of continuous ventricular extrasystole with detajmiumbitartrate (Tachmalcor)--clinical studies on effectiveness and dose-time-effect relations including intraindividual therapy comparisons with ajmaline (Tachmalin) Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(16): 519-525
Mizon, J.P.; Gentit, F. 1975: Cephalexin in internal medicine. Antibacterial treatment in 30 patients, 10 of them with malignant hemopathies, including 6 cases of agranulocytosis (granulocytes 1500/mm3) Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 20(1): 58-60
Riboulet, G.; Efthymiou, M.L.; Conso, F.; Garnier, R.; Caramela, P.; Gaultier, M. 1979: Acute intoxication by ajmaline Veterinary and Human Toxicology 21 Suppl: 91-92
Ilyas, M. 1981: Ajmaline in the management of cardiac arrhythmias Jpma. Journal of the Pakistan Medical Association 31(7): 153-155